Generated: May 1, 2017
|Title:||Pharmaceutically useful polymorphic modification of buspirone|
|Abstract:||"Buspirone hydrochloride can exist in two polymorphic forms and the newly discoverd lower melting form, which is thermodynamically favored at pharmaceutically relevant temperatures, offers advantage in manufacture of buspirone pharmaceutical compositions".|
|Inventor(s):||Simms, deceased; Jack C. (late of Elberfeld, IN)|
|Assignee:||Bristol-Myers Squibb Co. (New York, NY)|
1. The lower melting polymorphic crystalline form of buspirone hydrochloride, characterized by a melting point of about 188.degree. C., in pharmaceutically purified form.
2. A method for treating anxiety in a patient in need of such treatment comprising administering an amount of the lower melting buspirone hydrochloride polymorph in pharmaceutically purified form of claim 1 effective for such treatment.
3. A pharmaceutical composition comprising the lower melting buspirone hydrochloride polymorph in pharmaceutically purified form of claim 1 and a carrier.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.